Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FSHD region gene 2 family member K, pseudogene (FRG2KP)
- Target
- FRG2KP
- Molecular classification
- Other (Pseudogene)
01
Overview
FRG2KP (FSHD region gene 2 family member K, pseudogene) is annotated as a human pseudogene related to the FRG2 gene family[5]. Pseudogenes are inheritable genetic elements that resemble functional genes but contain disabling mutations (e.g., premature stop codons, frameshifts) preventing their normal transcription or translation[2][6]. While some pseudogenes may generate RNA transcripts that play regulatory roles (such as acting as siRNAs or competing endogenous RNAs for gene regulation)[4], there is no evidence that FRG2KP serves any protein-coding or established regulatory function. FRG2KP is not considered a therapeutic target in biomedical research, nor is it associated with disease pathology, drug interactions, or clinical biomarkers[1][5]. In summary, FRG2KP is a non-functional pseudogene with no known biological or clinical significance for drug targeting or therapy.
- Other names
- FRG2KPHGNC: 51797NCBI Gene: 102724018Ensembl: ENSG00000261741
02
Mechanism of action
No drug mechanism of action is reported or applicable for FRG2KP.
03
Biological functions
As a pseudogene, it does not encode a functional protein. Pseudogenes may have regulatory RNA functions in some contexts (e.g., acting as competing endogenous RNA or generating siRNAs), but no specific biological function is reported for FRG2KP.
04
Disease associations
While FRG2 (not FRG2KP) is studied as an FSHD candidate gene, FRG2KP is only mentioned as a genomic pseudogene with no direct disease association. No evidence links FRG2KP directly to disease processes.
Beyond the preview
Go deeper on FSHD region gene 2 family member K, pseudogene (FRG2KP).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FSHD region gene 2 family member K, pseudogene (FRG2KP).